GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (TSXV:AVCR) » Definitions » EV-to-FCF

Avricore Health (TSXV:AVCR) EV-to-FCF : 13.65 (As of Apr. 03, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Avricore Health EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Avricore Health's Enterprise Value is C$4.82 Mil. Avricore Health's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.35 Mil. Therefore, Avricore Health's EV-to-FCF for today is 13.65.

The historical rank and industry rank for Avricore Health's EV-to-FCF or its related term are showing as below:

TSXV:AVCR' s EV-to-FCF Range Over the Past 10 Years
Min: -44.66   Med: -3.86   Max: 317.51
Current: 15.08

During the past 13 years, the highest EV-to-FCF of Avricore Health was 317.51. The lowest was -44.66. And the median was -3.86.

TSXV:AVCR's EV-to-FCF is ranked better than
69.52% of 105 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.44 vs TSXV:AVCR: 15.08

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-03), Avricore Health's stock price is C$0.05. Avricore Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.003. Therefore, Avricore Health's PE Ratio (TTM) for today is 16.67.


Avricore Health EV-to-FCF Historical Data

The historical data trend for Avricore Health's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health EV-to-FCF Chart

Avricore Health Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.30 -5.99 -9.92 -18.62 -43.13

Avricore Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.62 -43.13 165.14 162.41 49.23

Competitive Comparison of Avricore Health's EV-to-FCF

For the Diagnostics & Research subindustry, Avricore Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avricore Health's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Avricore Health's EV-to-FCF falls into.


;
;

Avricore Health EV-to-FCF Calculation

Avricore Health's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4.818/0.353
=13.65

Avricore Health's current Enterprise Value is C$4.82 Mil.
Avricore Health's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avricore Health  (TSXV:AVCR) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Avricore Health's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.05/0.003
=16.67

Avricore Health's share price for today is C$0.05.
Avricore Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.003.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Avricore Health EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Avricore Health's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and the sale of testing panels.
Executives
Kiriaki Smith Senior Officer
Rodger Mckendry Seccombe Senior Officer
Alan Arnstein Director
David Farnfield Director
David M. Hall Director
Inc. Emerald Health Therapeutics 10% Security Holder
Sukhwinder Singh Rai Director

Avricore Health Headlines

No Headlines